CIK: 1583977 - Address: 200 Clarendon Street, 52Nd Floor, Boston, MA 02116
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/8/24 16:23
5/6/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumCormorant Asset Management, LPMATP10,08211.860850118,325I
4/22/24 16:00
4/18/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumCormorant Asset Management, LPMATP10,48918.03058287,475I
4/3/24 17:37
4/1/24
IMRXImmuneering CorpDEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMATS-1,1602.900-400-122,895I
3/18/24 17:59
3/14/24
IMRXImmuneering CorpDEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMATS.m-2,7493.020-909-223,295I
3/11/24 17:34
3/7/24
CRBPCorbus Pharmaceuticals Holdings, Inc.DEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMATP.m23,32842.410550372,025I
2/6/24 16:00
2/2/24
CRBPCorbus Pharmaceuticals Holdings, Inc.DEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMATP14,25019.0007501031,475I
1/30/24 16:23
1/26/24
CRBPCorbus Pharmaceuticals Holdings, Inc.DEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMATP9,11232.24028364725I
1/11/24 16:00
1/9/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumCormorant Asset Management, LPMATP.m17,05119.940855146,893I
12/12/23 16:52
12/8/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumCormorant Asset Management, LPMATP10,00017.000588116,038I
12/6/23 16:39
12/4/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumCormorant Asset Management, LPMATP41,87421.8201,919545,450I
10/25/23 16:15
10/23/23
AMAMAmbrx Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMATP9,1406.9901,3071311,231I
9/19/23 16:49
9/15/23
AMAMAmbrx Biopharma Inc.E9HealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMATP.m19,6269.1202,153369,466I
7/24/23 16:01
7/20/23
GRNAGreenlight Biosciences Holdings, PbcDEHealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMAH(See belS00.000-9,189-1000I
4/20/23 18:04
4/18/23
AMAMAmbrx Biopharma Inc.E9HealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMATP.m58,95111.3005,215867,313I
4/17/23 17:46
4/13/23
AMAMAmbrx Biopharma Inc.E9HealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMATP.m25,3199.7502,598462,098I
3/16/23 18:04
3/14/23
AMAMAmbrx Biopharma Inc.E9HealthBioPrdBiological Products, (No DiagCormorant Asset Management, LPMATP.m10,21110.2101,000253,500I
10/27/21 16:04
10/25/21
VTYXVentyx Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMAHFormer 1P.d10,00016.000625801,410I
10/15/21 16:12
10/13/21
PYXSPyxis Oncology, Inc.DEHealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMAHFormer 1P.d7,20016.000450671,119I
9/21/21 16:03
9/17/21
TYRATyra Biosciences, Inc.HealthDrugPharmaceutical PreparationsCormorant Asset Management, LPMAHFormer 1P.d5,00016.000313411,070I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact